Silencing Protein to Beat Drug Resistance | Toledo News

Scientists at the University of Toledo are unlocking a major breakthrough in the fight against triple-negative breast cancer — a deadly, fast-spreading form that often resists chemotherapy. With a $370,000 grant from the National Cancer Institute, researchers are zeroing in on a key protein driving drug resistance, aiming to silence it and restore the effectiveness of existing treatments. Their work, part of a broader collaborative effort, could dramatically improve survival rates for patients facing relapse and metastasis to vital organs — offering hope where options were once scarce. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/6dd20423850612d9